A Long Road to a Final Verdict
American tennis player Jessica Eudovic has been handed a two-year ban by the International Tennis Integrity Agency after testing positive for clostebol, a synthetic anabolic steroid that has made headlines across the sport in recent years. The positive test occurred at a World Tennis Tour event in Santa Tecla, El Salvador, back in October 2025, and Eudovic has already spent over a year under provisional suspension while contesting the case.
Eudovic challenged the initial ruling, pushing the matter to an independent tribunal that held a two-day hearing in October. Despite the legal fight, the two-year sanction was upheld. With time already served credited toward the ban, her suspension is set to expire on November 20, 2027. Crucially, the tribunal determined that the breach was not intentional, noting the very low concentration of the substance detected, but because Eudovic could not explain how clostebol entered her system, the panel was unable to reduce the penalty further. Her results from the Santa Tecla event have been disqualified, with prize money and ranking points forfeited.
Career Disruption for a Player Still Finding Her Feet
The timing has been brutal for Eudovic, whose early professional career has been effectively paused. She has not competed since appearing at a World Tennis Tour event in Boca Raton in November of last year, and she is not permitted to play, coach, or attend any ATP, WTA, Grand Slam, or national association events while suspended.
Clostebol has become an increasingly familiar name in tennis doping cases. Jannik Sinner reached a settlement with the ITIA and missed roughly three months of action following his own positive test for the substance. Eudovic's situation is notably harsher, though she will still be just 20 years old when eligible to return, leaving room for a potential comeback. TennisDraw users tracking the sport's rising generation will want to keep her name in mind for future bracket considerations.



